{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:33:09Z","timestamp":1789914789966,"version":"4.0.1"},"reference-count":73,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["clinical-practice-and-epidemiology-in-mental-health.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["CPEMH"],"published-print":{"date-parts":[[2018,10,30]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Medication of acute episodes of mood disorders has changed over the last decades following the results of randomized clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The aim of this study was to analyze medication prescribed at discharge from two psychiatric wards. We focused on hospitalization as one of the best opportunities to start prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We examined retrospectively the clinical records of 357 patients hospitalized for mood episodes in two psychiatric wards in the Cagliari area (SPDC-1 and SPDC-2) between 1 January and 31 December 2016. We focused on the psychotropic medication prescribed at discharge from the hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most patients were discharged with antipsychotics (86%) and\/or benzodiazepines (89%). Combined medication was frequent, including various co-administration of first-generation and\/or second-generation antipsychotics (26% of patients), or antipsychotics combined with mood-stabilizers (51% of patients). There was a preferential prescription of first-generation antipsychotics in SPDC-1, and of second-generation antipsychotics in SPDC-2. Prescription of lithium was significantly more frequent in SPDC-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Although the treatment was in line with randomized clinical trials, the choice of individual psychotropic agents differed significantly between the two wards. Different prescription attitudes can have consequences on the long-term outcome of patients discharged from the hospital after an acute mood episode.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1745017901814010236","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T23:47:41Z","timestamp":1551829661000},"page":"236-249","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Psychotropic Medication of Acute Episodes of Mood Disorders: Current Prescription Attitude in Two Psychiatric Wards in Cagliari, Italy"],"prefix":"10.2174","volume":"14","author":[{"given":"Gioia","family":"Baggiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ambrosiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfranco","family":"Trincas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Burrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bocchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/bdi.12371","volume":"18","author":"Kessing L.V.","year":"2016","unstructured":"Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord 2016; 18 (2) : 174-82.","journal-title":"Bipolar Disord."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Bocchetta A. Bipolar Disorder. Clinical trials in psychopharmacology - A better brain 2010; 125-47.","DOI":"10.1002\/9780470749180.ch7"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","volume":"381","author":"Geddes J.R.","year":"2013","unstructured":"Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013; 381 (9878) : 1672-82.","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","volume":"1","author":"Miura T.","year":"2014","unstructured":"Miura T, Noma H, Furukawa TA, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: A systematic review and network meta-analysis. Lancet Psychiatry 2014; 1 (5) : 351-9.","journal-title":"Lancet Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","volume":"387","author":"Grande I.","year":"2016","unstructured":"Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet 2016; 387 (10027) : 1561-72.","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1399-5618.2009.00712.x","volume":"11","author":"Coryell W.","year":"2009","unstructured":"Coryell W. Maintenance treatment in bipolar disorder: A reassessment of lithium as the first choice. Bipolar Disord 2009; 11 (Suppl. 2) : 77-83.","journal-title":"Bipolar Disord."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40345-015-0032-2","volume":"3","author":"Lewitzka U.","year":"2015","unstructured":"Lewitzka U, Severus E, Bauer R, Ritter P, M\u00fcller-Oerlinghausen B, Bauer M. The suicide prevention effect of lithium: More than 20 years of evidence-a narrative review. Int J Bipolar Disord 2015; 3 (1) : 32.","journal-title":"Int. J. Bipolar Disord."},{"key":"ref8","unstructured":"Perugi G, Fornaro M. Bipolar disorder treatment guidelines and their limits in every day clinical practice. Giorn Ital Psicopat 2011; 17 : 261-4. Available from: http:\/\/www.jpsychopathol.it\/article\/bipolar-disorder-treatment-guidelines-and-their-limits-in-every-day-clinical-practice\/"},{"key":"ref9","unstructured":"Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care 2018."},{"key":"ref10","unstructured":"Invernizzi G. Community psychiatry in Italy 1998. Available from: http:\/\/www.psychiatryonline.it\/node\/3947"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","volume":"2","author":"Cade J.F.","year":"1949","unstructured":"Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 2 (10) : 349-52.","journal-title":"Med. J. Aust."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/jnnp.17.4.250","volume":"17","author":"Schou M.","year":"1954","unstructured":"Schou M, Juel-Nielsen N, Str\u00f6mgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 1954; 17 (4) : 250-60.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/j.1440-1614.2005.01649.x","volume":"39","author":"Muzina D.J.","year":"2005","unstructured":"Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: Focus on randomized controlled trials. Aust N Z J Psychiatry 2005; 39 (8) : 652-61.","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","volume":"9","author":"Smith L.A.","year":"2007","unstructured":"Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Pharmacological interventions for acute bipolar mania: A systematic review of randomized placebo-controlled trials. Bipolar Disord 2007; 9 (6) : 551-60.","journal-title":"Bipolar Disord."},{"key":"ref15","first-page":"CD004362","author":"Cipriani A.","year":"2006","unstructured":"Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev 2006; (3): CD004362.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1176\/ajp.153.6.759","volume":"153","author":"Calabrese J.R.","year":"1996","unstructured":"Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996; 153 (6) : 759-64.","journal-title":"Am. J. Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","volume":"156","author":"Suppes T.","year":"1999","unstructured":"Suppes T, Webb A, Paul B, Carmody T, Kraemer H, Rush AJ. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999; 156 (8) : 1164-9.","journal-title":"Am. J. Psychiatry"},{"key":"ref18","first-page":"CD006633","author":"Asenjo Lobos C.","year":"2010","unstructured":"Asenjo Lobos C, Komossa K, Rummel-Kluge C, et al. Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; (11): CD006633.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archpsyc.60.1.82","volume":"60","author":"Meltzer H.Y.","year":"2003","unstructured":"Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003; 60 (1) : 82-91.","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"Tiihonen J.","year":"2009","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study). Lancet 2009; 374 (9690) : 620-7.","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/pds.3567","volume":"23","author":"Ringb\u00e4ck Weitoft G.","year":"2014","unstructured":"Ringb\u00e4ck Weitoft G, Berglund M, Lindstr\u00f6m EA, Nilsson M, Salmi P, Ros\u00e9n M. Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in sweden-a register-based study. Pharmacoepidemiol Drug Saf 2014; 23 (3) : 290-8.","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00023210-200721010-00005","volume":"21","author":"Post R.M.","year":"2007","unstructured":"Post RM, Ketter TA, Uhde T, Ballenger JC. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: Principles and practice. CNS Drugs 2007; 21 (1) : 47-71.","journal-title":"CNS Drugs"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4088\/JCP.v65n0405","volume":"65","author":"Weisler R.H.","year":"2004","unstructured":"Weisler RH, Kalali AH, Ketter TA. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 2004; 65 (4) : 478-84.","journal-title":"J. Clin. Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4088\/JCP.v66n0308","volume":"66","author":"Weisler R.H.","year":"2005","unstructured":"Weisler RH, Keck PE Jr, Swann AC, Cutler AJ, Ketter TA, Kalali AH. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2005; 66 (3) : 323-30.","journal-title":"J. Clin. Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0165-0327(96)01427-9","volume":"43","author":"Greil W.","year":"1997","unstructured":"Greil W, Ludwig-Mayerhofer W, Erazo N, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study. J Affect Disord 1997; 43 (2) : 151-61.","journal-title":"J. Affect. Disord."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4088\/JCP.v64n0206","volume":"64","author":"Hartong E.G.","year":"2003","unstructured":"Hartong EG, Moleman P, Hoogduin CA, Broekman TG, Nolen WA. Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients. J Clin Psychiatry 2003; 64 (2) : 144-51.","journal-title":"J. Clin. Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00004714-199704000-00005","volume":"17","author":"Bocchetta A.","year":"1997","unstructured":"Bocchetta A, Chillotti C, Severino G, Ardau R, Del Zompo M. Carbamazepine augmentation in lithium-refractory bipolar patients: A prospective study on long-term prophlyactic effectiveness. J Clin Psychopharmacol 1997; 17 (2) : 92-6.","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1176\/ajp.153.5.711","volume":"153","author":"Fenn H.H.","year":"1996","unstructured":"Fenn HH, Robinson D, Luby V, et al. Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: A 5-year naturalistic study. Am J Psychiatry 1996; 153 (5) : 711-3.","journal-title":"Am. J. Psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1176\/appi.ajp.159.6.1005","volume":"159","author":"Blanco C.","year":"2002","unstructured":"Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry 2002; 159 (6) : 1005-10.","journal-title":"Am. J. Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/jama.290.11.1467","volume":"290","author":"Goodwin F.K.","year":"2003","unstructured":"Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290 (11) : 1467-73.","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","volume":"10","author":"Calabrese J.R.","year":"2008","unstructured":"Calabrese JR, Huffman RF, White RL, et al. Lamotrigine in the acute treatment of bipolar depression: Results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008; 10 (2) : 323-33.","journal-title":"Bipolar Disord."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4088\/JCP.v65n0321","volume":"65","author":"Goodwin G.M.","year":"2004","unstructured":"Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65 (3) : 432-41.","journal-title":"J. Clin. Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/acps.12427","volume":"132","author":"Parker G.","year":"2015","unstructured":"Parker G, McCraw S. The \u2018disconnect\u2019 between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications. Acta Psychiatr Scand 2015; 132 (5) : 345-54.","journal-title":"Acta Psychiatr. Scand."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/acps.12436","volume":"132","author":"Bowden C.L.","year":"2015","unstructured":"Bowden CL. Common sources of disparate results and experience in clinical practice vs. results from phase 2 registration studies: lamotrigine as a prototype. Acta Psychiatr Scand 2015; 132 (5) : 355-6.","journal-title":"Acta Psychiatr. Scand."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.4088\/JCP.13010tx2c","volume":"75","author":"Ketter T.A.","year":"2014","unstructured":"Ketter TA. Acute and maintenance treatments for bipolar depression. J Clin Psychiatry 2014; 75 (4) : e10.","journal-title":"J. Clin. Psychiatry"},{"key":"ref36","first-page":"CD004857","author":"Vasudev A.","year":"2011","unstructured":"Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH. Oxcarbazepine for acute affective episodes in bipolar disorder. Cochrane Database Syst Rev 2011; (12): CD004857.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref37","first-page":"CD003384","volume":"9","author":"Pigott K.","year":"2016","unstructured":"Pigott K, Galizia I, Vasudev K, Watson S, Geddes J, Young AH. Topiramate for acute affective episodes in bipolar disorder in adults. Cochrane Database Syst Rev 2016; 9 : CD003384.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e013433","DOI":"10.1136\/bmjopen-2016-013433","volume":"7","author":"Houghton K.T.","year":"2017","unstructured":"Houghton KT, Forrest A, Awad A, et al. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: Protocol for a systematic review and meta-analysis. BMJ Open 2017; 7 (3) : e013433.","journal-title":"BMJ Open"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/acps.12223","volume":"129","author":"Cipriani A.","year":"2014","unstructured":"Cipriani A, Barbui C, Rendell J, Geddes JR. Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder. Acta Psychiatr Scand 2014; 129 (5) : 328-42.","journal-title":"Acta Psychiatr. Scand."},{"key":"ref40","first-page":"47","volume":"53","author":"Lenox R.H.","year":"1992","unstructured":"Lenox RH, Newhouse PA, Creelman WL, Whitaker TM. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: A double-blind study. J Clin Psychiatry 1992; 53 (2) : 47-52.","journal-title":"J. Clin. Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0165-0327(02)00317-8","volume":"78","author":"Curtin F.","year":"2004","unstructured":"Curtin F, Schulz P. Clonazepam and lorazepam in acute mania: A Bayesian meta-analysis. J Affect Disord 2004; 78 (3) : 201-8.","journal-title":"J. Affect. Disord."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1034\/j.1399-5618.2000.020106.x","volume":"2","author":"Keck P.E.","year":"2000","unstructured":"Keck PE Jr, McElroy SL, Bennett JA. Pharmacologic loading in the treatment of acute mania. Bipolar Disord 2000; 2 (1) : 42-6.","journal-title":"Bipolar Disord."},{"key":"ref43","first-page":"92","volume":"29","author":"Correll C.U.","year":"2017","unstructured":"Correll CU, Yu X, Xiang Y, Kane JM, Masand P. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting. Ann Clin Psychiatry 2017; 29 (2) : 92-107.","journal-title":"Ann. Clin. Psychiatry"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40263-015-0235-1","volume":"29","author":"Grande I.","year":"2015","unstructured":"Grande I, Vieta E. Pharmacotherapy of acute mania: Monotherapy or combination therapy with mood stabilizers and antipsychotics? CNS Drugs 2015; 29 (3) : 221-7.","journal-title":"CNS Drugs"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1177\/0004867415614109","volume":"49","author":"Glue P.","year":"2015","unstructured":"Glue P, Herbison P. Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis. Aust N Z J Psychiatry 2015; 49 (12) : 1215-20.","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2147\/NDT.S100846","volume":"12","author":"Fornaro M.","year":"2016","unstructured":"Fornaro M, De Berardis D, Koshy AS, et al. Prevalence and clinical features associated with bipolar disorder polypharmacy: A systematic review. Neuropsychiatr Dis Treat 2016; 12 : 719-35.","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Bauer M, Gitlin M. The essential guide to lithium treatment 2016.","DOI":"10.1007\/978-3-319-31214-9"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jad.2016.01.043","volume":"195","author":"Karanti A.","year":"2016","unstructured":"Karanti A, Kardell M, Lundberg U, Land\u00e9n M. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord 2016; 195 : 50-6.","journal-title":"J. Affect. Disord."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00004714-199810000-00006","volume":"18","author":"Bocchetta A.","year":"1998","unstructured":"Bocchetta A, Ardau R, Burrai C, Chillotti C, Quesada G, Del Zompo M. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts. J Clin Psychopharmacol 1998; 18 (5) : 384-9.","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-2001-15878","volume":"34","author":"Ahrens B.","year":"2001","unstructured":"Ahrens B, M\u00fcller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry 2001; 34 (4) : 132-6.","journal-title":"Pharmacopsychiatry"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-2007-979553","volume":"29","author":"Thies-Flechtner K.","year":"1996","unstructured":"Thies-Flechtner K, M\u00fcller-Oerlinghausen B, Seibert W, Walther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 1996; 29 (3) : 103-7.","journal-title":"Pharmacopsychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2007.07.014","volume":"107","author":"Collins J.C.","year":"2008","unstructured":"Collins JC, McFarland BH. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2008; 107 (1-3) : 23-8.","journal-title":"J. Affect. Disord."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","volume":"162","author":"Cipriani A.","year":"2005","unstructured":"Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162 (10) : 1805-19.","journal-title":"Am. J. Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"f3646","DOI":"10.1136\/bmj.f3646","volume":"346","author":"Cipriani A.","year":"2013","unstructured":"Cipriani A, Hawton K, Stockton S, Geddes JR. Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis. BMJ 2013; 346 : f3646.","journal-title":"BMJ"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jamapsychiatry.2017.4711","volume":"75","author":"L\u00e4hteenvuo M.","year":"2018","unstructured":"L\u00e4hteenvuo M, Tanskanen A, Taipale H, et al. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry 2018; 75 (4) : 347-55.","journal-title":"JAMA Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12623","author":"Kessing L.V.","year":"2018","unstructured":"Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J. Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: A systematic review of evidence from observational studies. Bipolar Disord 2018. Epub ahead of print","journal-title":"Bipolar Disord."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1517\/14740338.2015.1053457","volume":"14","author":"Galling B.","year":"2015","unstructured":"Galling B, Garcia MA, Osuchukwu U, Hagi K, Correll CU. Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: Results from a systematic review and exploratory meta-analysis. Expert Opin Drug Saf 2015; 14 (8) : 1181-99.","journal-title":"Expert Opin. Drug Saf."},{"key":"ref58","first-page":"CD005000","author":"Brown R.","year":"2013","unstructured":"Brown R, Taylor MJ, Geddes J. Aripiprazole alone or in combination for acute mania. Cochrane Database Syst Rev 2013; (12): CD005000.","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref59","first-page":"459","volume":"10","author":"Sayyaparaju K.K.","year":"2014","unstructured":"Sayyaparaju KK, Grunze H, Fountoulakis KN. When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatr Dis Treat 2014; 10 : 459-70.","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pnpbp.2017.06.023","volume":"79","author":"Li DJ","year":"2017","unstructured":"Li DJ, Tseng PT, Stubbs B, et al. . Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials. Prog Neuropsychopharmacol Biol Psychiatry 2017; 79 ((Pt B)) : 289-301.","journal-title":"Prog. Neuropsychopharmacol Biol. Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12916-014-0249-4","volume":"13","author":"Bocchetta A.","year":"2015","unstructured":"Bocchetta A, Ardau R, Fanni T, et al. Renal function during long-term lithium treatment: A cross-sectional and longitudinal study. BMC Med 2015; 13 : 12.","journal-title":"BMC Med."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40345-017-0096-2","volume":"5","author":"Tondo L.","year":"2017","unstructured":"Tondo L, Abramowicz M, Alda M, et al. Long-term lithium treatment in bipolar disorder: Effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord 2017; 5 (1) : 27.","journal-title":"Int. J. Bipolar Disord."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/YIC.0b013e3281c61b28","volume":"22","author":"Dealberto M.J.","year":"2007","unstructured":"Dealberto MJ. Valproate-induced hyperammonaemic encephalopathy: Review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol 2007; 22 (6) : 330-7.","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00004714-200212000-00019","volume":"22","author":"Raja M.","year":"2002","unstructured":"Raja M, Azzoni A. Valproate-induced hyperammonaemia. J Clin Psychopharmacol 2002; 22 (6) : 631-3.","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/JCP.0b013e318240a4a7","volume":"32","author":"Bocchetta A.","year":"2012","unstructured":"Bocchetta A, Siddu A, Sardu C, Sarnicola A, Martinelli V. Ammonemia in bipolar patients on maintenance treatment with valproic acid. J Clin Psychopharmacol 2012; 32 (1) : 148-50.","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","volume":"271","author":"Bowden C.L.","year":"1994","unstructured":"Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271 (12) : 918-24.","journal-title":"JAMA"},{"key":"ref67","first-page":"345","volume":"22","author":"Ravindran A.V.","year":"1997","unstructured":"Ravindran AV, Jones BW, al-Zaid K, Lapierre YD. Effective treatment of mania with olanzapine: 2 case reports. J Psychiatry Neurosci 1997; 22 (5) : 345-6.","journal-title":"J. Psychiatry Neurosci."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1192\/bjp.167.5.569","volume":"167","author":"Moncrieff J.","year":"1995","unstructured":"Moncrieff J. Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Br J Psychiatry 1995; 167 (5) : 569-73.","journal-title":"Br. J. Psychiatry"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1192\/bjp.168.6.789a","volume":"168","author":"Moncrieff J.","year":"1996","unstructured":"Moncrieff J. Lithium revisited. Br J Psychiatry 1996; 168 (6) : 789.","journal-title":"Br. J. Psychiatry"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1192\/bjp.171.2.113","volume":"171","author":"Moncrieff J.","year":"1997","unstructured":"Moncrieff J. Lithium: Evidence reconsidered. Br J Psychiatry 1997; 171 (2) : 113-9.","journal-title":"Br. J. Psychiatry"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archpsyc.55.1.92","volume":"55","author":"Moncrieff J.","year":"1998","unstructured":"Moncrieff J. Forty years of lithium treatment. Arch Gen Psychiatry 1998; 55 (1) : 92-3.","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Moncrieff J. BALANCE investigators and collaborators. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): A randomised open-label trial. Lancet 2010; 375 (9712) : 385-95.","DOI":"10.1016\/S0140-6736(09)61828-6"},{"key":"ref73","first-page":"CD003196","author":"Cipriani A.","year":"2013","unstructured":"Cipriani A, Reid K, Young AH, Macritchie K, Geddes J. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2013; (10): CD003196.","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Clinical Practice &amp; Epidemiology in Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/contents\/volumes\/V14\/CPEMH-14-236\/CPEMH-14-236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/contents\/volumes\/V14\/CPEMH-14-236\/CPEMH-14-236.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/contents\/volumes\/V14\/CPEMH-14-236\/CPEMH-14-236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T21:30:52Z","timestamp":1663018252000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/VOLUME\/14\/PAGE\/236\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10,30]]}},"alternative-id":["CPEMH-14-236"],"URL":"https:\/\/doi.org\/10.2174\/1745017901814010236","relation":{},"ISSN":["1745-0179"],"issn-type":[{"value":"1745-0179","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-5-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-9-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-2","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}